He was formerly President, CEO, and Chairman of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a company focused on developing drugs for ophthalmic diseases. Stephen led EyeGate for over 10 years and successfully took it public and completed multiple acquisitions of ophthalmic companies and licensing deals. Prior to this, he was the Chief Financial Officer at Centelion SAS, an independent biotechnology subsidiary of Sanofi-Aventis. Stephen spent several years as an investment banker specializing in the biotechnology and medical device sectors. He served as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Stephen holds a BS from the University of Western Ontario and an accounting diploma from Wilfred Laurier University.